PCM
FMTX

Prelude Capital Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Prelude Capital Management’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-171,295
Closed -$3.42M – 1928
2022
Q3 		$3.42M Buy
+171,295
New +$2.26M 0.12% 133

Prelude Capital Management's FMTX Position: Q4 2022 in Review

Prelude Capital Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 171,295 shares — an estimated $3.42M sold.

Prelude Capital Management first reported a position in FMTX in Q3 2022 and held it in 1 quarter. The position peaked at $3.42M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Prelude Capital Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Prelude Capital Management sold 171,295 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $3.42M.
  • Prelude Capital Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Prelude Capital Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $3.42M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.